Loading…
PMV Pharmaceuticals, Inc. is projected to rise to $1.35 by 2027, a +22% move from its current price of $1.12. PMVP is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/4/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $1.08 | $1.12 | $1.16 | -0.07% |
| Aug 6 | $1.06 | $1.12 | $1.18 | -0.13% |
| Aug 7 | $1.05 | $1.12 | $1.19 | -0.20% |
| Aug 8 | $1.04 | $1.12 | $1.20 | -0.26% |
| Aug 9 | $1.03 | $1.12 | $1.21 | -0.33% |
| Aug 10 | $1.02 | $1.12 | $1.22 | -0.39% |
| Aug 11 | $1.01 | $1.11 | $1.23 | -0.46% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.01 | $1.11 | $1.23 | -0.46% |
| Week 2 | $0.9696 | $1.11 | $1.27 | -0.92% |
| Week 3 | $0.9362 | $1.10 | $1.30 | -1.37% |
| Week 4 | $0.9084 | $1.10 | $1.33 | -1.83% |
| Week 5 | $0.8841 | $1.09 | $1.35 | -2.28% |
| Week 6 | $0.8623 | $1.09 | $1.38 | -2.73% |
| Week 7 | $0.8424 | $1.08 | $1.40 | -3.17% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
PMV Pharmaceuticals, Inc. is a healthcare company focused on precision oncology. It engages in the discovery and development of small molecule therapies targeting p53 mutations and other p53-related cancers in the United States.
The company develops rezatapopt, a selective structural corrector of p53 Y220C mutations in Phase 2 clinical trials for tumor agnostic diseases. PMV Pharmaceuticals, Inc. was formerly known as PJ Pharmaceuticals, Inc.
and changed its name to PMV Pharmaceuticals, Inc. in July 2013. PMV Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Princeton, New Jersey.
PMV Pharmaceuticals, Inc. (PMVP) is a healthcare stock that currently trades at $1.07 per share and has a market capitalization of $57.06M. It ranks 4481 by market cap.
The near-term technical picture is Bearish. RSI(14) is 40, with the 50-day simple moving average at $1.21 and the 200-day simple moving average at $1.29. The stock’s current support is $1.07 and resistance is $1.42. Over the last 30 days, the price range has spanned from $0.8418 to $1.36.
Looking further out, the multi-year forecast outlines a bullish trajectory with year-by-year targets. The 2026 min is $1.02, avg $1.07, max $1.37; 2027 min $0.9885, avg $1.28, max $1.77; 2028 min $1.09, avg $1.47, max $2.13; 2029 min $1.17, avg $1.63, max $2.44; 2030 min $1.08, avg $1.54, max $2.39; 2031 min $1.07, avg $1.57, max $2.51; 2032 min $1.12, avg $1.69, max $2.76; 2033 min $1.02, avg $1.56, max $2.61; 2034 min $1.29, avg $2.04, max $3.46; 2035 min $1.55, avg $2.49, max $4.31; 2040 min $1.59, avg $2.83, max $5.27; 2050 min $2.54, avg $5.42, max $11.26. ROI figures accompany these paths, with 2030 at 44.1, 2040 at 164, and 2050 at 406.6, all with bullish sentiment.
A major floor 24.1% below — a decisive break under it would weaken the trend.
The nearest floor, 4.5% below — buyers have tended to step in here.
The nearest ceiling, 26.8% above — a clean break opens room to run.
A major ceiling 38.4% above — clearing it would confirm fresh momentum.
Key PMVP support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of PMVP market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $1.12 | Buy | $1.14 | Sell |
| MA 10 | $1.21 | Sell | $1.18 | Sell |
| MA 20 | $1.25 | Sell | $1.21 | Sell |
| MA 50 | $1.21 | Sell | $1.24 | Sell |
| MA 100 | $1.30 | Sell | $1.26 | Sell |
| MA 200 | $1.29 | Sell | $1.29 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 40.37 | Neutral |
| Stoch RSI (14) | 14.42 | Buy |
| CCI (20) | -125.48 | Sell |
| Williams %R (14) | -88.57 | Info |
| MACD (12,26,9) | -0.03 | Sell |
| ROC (12) | -20.71 | Sell |
| Bollinger %B (20,2) | 0.13 | Neutral |
| Stochastic %K (14) | 11.43 | Buy |
| TRIX (15) | 0.07 | Buy |
| Awesome (5,34) | -0.10 | Sell |
| Ultimate (7,14,28) | 28.11 | Buy |
| Momentum (10) | -0.23 | Sell |
| Aroon Osc (25) | -44.00 | Sell |
| Hull MA (9) | 1.05 | Buy |
| ADX (14) | 15.74 | Neutral |
| ATR (14) | 0.04 | Info |
In the near term, the setup remains Bearish, with an RSI of 40 and price trading near a defined support at $1.07. The SMA(50) sits at $1.21, while the SMA(200) sits at $1.29, indicating potential resistance above the current level. The stock’s 30-day range runs from $0.8418 to $1.36, framing a constrained trading window in the low single digits.
Traders may watch for a break above $1.42 to signal a shift toward resistance-turned-support, or a drop below $1.07 to expand downside risk. Given the current indicators, momentum is not favorable in the immediate term, but the longer-term forecast projects a bullish path beyond 2026.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.02 | $1.11 | $1.43 | 0% | Neutral | |
| $1.05 | $1.35 | $1.86 | +22% | Bullish | |
| $1.15 | $1.55 | $2.24 | +40% | Bullish | |
| $1.25 | $1.73 | $2.59 | +56% | Bullish | |
| $1.15 | $1.64 | $2.54 | +48% | Bullish | |
| $1.14 | $1.67 | $2.66 | +51% | Bullish | |
| $1.22 | $1.83 | $2.97 | +65% | Bullish | |
| $1.11 | $1.71 | $2.84 | +54% | Bullish | |
| $1.41 | $2.21 | $3.75 | +99% | Bullish | |
| $1.69 | $2.71 | $4.68 | +144% | Bullish | |
| $1.76 | $3.12 | $5.79 | +181% | Bullish | |
| $2.85 | $6.04 | $12.49 | +444% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $1.02 | $1.11 | $1.38 | -0.89% |
| September 2026 | $0.9268 | $1.11 | $1.36 | -0.34% |
| October 2026 | $0.8755 | $1.05 | $1.32 | -4.66% |
| November 2026 | $0.8924 | $1.08 | $1.37 | +2.69% |
| December 2026 | $0.9126 | $1.12 | $1.43 | +2.96% |
Click any year to see its month-by-month PMVP forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The PMVP price prediction for 2026 points to an average of $1.11 (low $1.02, high $1.43) — a potential gain of 0% on today's $1.12. Price action looks broadly range-bound.
In 2027, PMVP is projected to trade between $1.05 and $1.86, averaging $1.35 — a potential gain of +22% from today's $1.12. That is up +22% on the projected 2026 average. Buyers look set to stay in control over this stretch.
PMV Pharmaceuticals, Inc.'s 2028 outlook centres on $1.55, within a $1.15 to $2.24 range. That is up +15% on the projected 2027 average. That marks a +40% change versus current levels. Momentum favours further upside here.
By 2029, PMVP could reach as high as $2.59, with a base case around $1.73 and support toward $1.25 — roughly +56% from $1.12. Buyers look set to stay in control over this stretch.
Expect PMVP to range from $1.15 to $2.54 through 2030. The $1.64 average target implies a +48% move from current prices. That is -5% versus the projected 2029 average. Momentum favours further upside here.
The PMVP price prediction for 2031 points to an average of $1.67 (low $1.14, high $2.66) — a potential gain of +51% on today's $1.12. Buyers look set to stay in control over this stretch.
In 2032, PMVP is projected to trade between $1.22 and $2.97, averaging $1.83 — a potential gain of +65% from today's $1.12. That is up +9% on the projected 2031 average. Momentum favours further upside here.
PMV Pharmaceuticals, Inc.'s 2033 outlook centres on $1.71, within a $1.11 to $2.84 range. That is -7% versus the projected 2032 average. That marks a +54% change versus current levels. Buyers look set to stay in control over this stretch.
By 2034, PMVP could reach as high as $3.75, with a base case around $2.21 and support toward $1.41 — roughly +99% from $1.12. Momentum favours further upside here.
Expect PMVP to range from $1.69 to $4.68 through 2035. The $2.71 average target implies a +144% move from current prices. That is up +23% on the projected 2034 average. Buyers look set to stay in control over this stretch.
The PMVP price prediction for 2040 points to an average of $3.12 (low $1.76, high $5.79) — a potential gain of +181% on today's $1.12. Momentum favours further upside here.
In 2050, PMVP is projected to trade between $2.85 and $12.49, averaging $6.04 — a potential gain of +444% from today's $1.12. That is up +94% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in PMVP today (≈ 892.857143 PMVP) could be worth
$5,388.7
+$4,388.7 (+439%) by 2050 · US Dollar
Based on the average projected PMVP price of $6.04 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in PMVPwould be worth at today's price.
$1,000 invested in PMVP on Jul 31, 2025 (≈ 704.225373 PMVP) would be worth
$788.73
-$211.27 (-21.1%) today · 0.79× · US Dollar
Based on a PMVP entry price of $1.42 vs. today's $1.12.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $1.24 | $903.23 | -9.7% |
| 1 month ago | $1.24 | $903.23 | -9.7% |
| 3 months ago | $1.39 | $805.76 | -19.4% |
| 6 months ago | $1.06 | $1,056.6 | +5.7% |
| 1 year ago | $1.42 | $788.73 | -21.1% |
| All time (5.0y) ago | $36.45 | $30.73 | -96.9% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our PMVP forecast.
Our base-case forecast reaches $2.20 around 2034.
Implied market cap at $2.20: $117.33M
The multi-year forecast shows a bullish trajectory for PMVP beyond the near term. In 2030, the average price is projected at $1.54, with a min of $1.08 and a max of $2.39, and an ROI of 44.1, signaling a meaningful upside opportunity within a higher-volatility equity. The sentiment for 2030 is bullish, reinforcing the case for longer-term upside as the equity navigates its risk profile.
Looking further to 2040, the average is forecast at $2.83, with a min of $1.59 and a max of $5.27, and an ROI of 164. The 2040 outlook remains bullish, suggesting continued price strengthening despite episodic volatility. By 2050, the average target reaches $5.42, the min is $2.54, the max is $11.26, and the ROI is 406.6 with a bullish label.
These are projections, not guarantees. The figures imply a bullish longer-term path but reflect uncertainty and potential volatility inherent to the asset and its sector.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $1.54, with a min of $1.08 and a max of $2.39, and an ROI of 44.1, with a bullish sentiment.
Forecasts point to a bullish long-term path, with the 2040 and 2050 targets showing strong upside (average $2.83 in 2040 and $5.42 in 2050; max values up to $5.27 and $11.26, respectively) and ROIs of 164 and 406.6. However, these are estimates and not guaranteed.
Yes. The 2040 max is $5.27 and the 2050 max is $11.26, with the 2040 and 2050 averages of $2.83 and $5.42, respectively.
By 2050, the average price is projected at $5.42, with a max of $11.26 and a min of $2.54, and an ROI of 406.6, with a bullish sentiment.
PMV Pharmaceuticals, Inc. Community Discussion
0Share your PMV Pharmaceuticals, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.